13.9 C
New York
Wednesday, April 14, 2021

CATEGORY

Business

Dr. Reddy’s [NYSE: RDY] Receives EUA for Sputnik V in India

Dr. Reddy's Laboratories Limited declared Monday that it has received the Emergency Use Authorization in India for Sputnik V. After the authorization, Dr....

Sanofi [NASDAQ: SNY] Announces Plan to Invest €400M in a Production Site in Singapore

Sanofi disclosed its plan on Monday that it has decided to invest €400 million in a prominent manufacturing site in Singapore. The firm...

Alibaba [NYSE: BABA] Decides to Accept Record Antitrust Fine by China

Alibaba Group Holding Limited declared Monday that it has decided to accept the heavy fine inflicted by anti-monopoly regulators of China.  The Chinese...

Regeneron [NASDAQ: REGN] Phase III Trial Result Shows Reducing Risk of Symptomatic Infections

Regeneron Pharmaceuticals, Inc. disclosed the Phase III trial outcome of newly infected asymptomatic COVID-19 sufferers. The firm has conducted the Phase III trial...

General Motors [NYSE: GM] Cancel Some US Truck Production Amid Chip Shortage

General Motors Company has disclosed that it has decided to terminate the production of some trucks this ongoing week at two U.S. auto...

Greenwich LifeSciences [NASDAQ: GLSI] Reports Positive Result of Phase IIb Trial

Shares of Greenwich LifeSciences, Inc. surged more than 12% during the pre-market trading session of Friday after the firm has reported the positive...

Cellectis [NASDAQ: CLLS] Finalizes Sale of $47M through its ATM Program

Cellectis S.A disclosed Friday that it has finalized the sales of nearly $47 million of ADS in accordance with the ATM program of...

Global Blood [NASDAQ: GBT] Announces Positive Results from Oxbryta’s Phase 3 HOPE Study

Global Blood Therapeutics, Inc. declared Thursday that it has received the positive results from the Phase III HOPE trial of Oxbryta. Global Blood...

Total [NYSE: TOT] Commence Producing Sustainable Aviation Fuel in France

TOTAL SE disclosed that it has commenced the production of sustainable aviation fuel in France. After starting the production, the firm will now...

Crinetics [NASDAQ: CRNX] to Raise $75M from Public Offering of Common Stock

Crinetics Pharmaceuticals, Inc. declared the pricing of an underwritten public offering of 4,562,044 shares of its common stock at a price to the...

Latest news